Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release
02 Ottobre 2023 - 10:30PM
Business Wire
Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen
Corporation, today announced that it plans to release its results
for the Fourth Quarter of Fiscal 2023 on Thursday, November 2,
2023, prior to the opening of trading on the New York Stock
Exchange. The Company will host a conference call to discuss the
results at 8:30 a.m. ET on November 2, 2023.
Participating in the conference call will be: Steven H. Collis,
Chairman, President & Chief Executive Officer James F. Cleary,
Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at
investor.cencora.com. Users are encouraged to log on to the webcast
approximately 10 minutes in advance of the scheduled start time of
the call.
To access the call via telephone from within the United States
and Canada, dial (833) 470-1428. From outside the United States and
Canada, dial +1 (404) 975-4839. The access code for the call will
be 016298.
Replays of the call will be made available via telephone and
webcast. A replay of the webcast will be posted on
investor.cencora.com approximately one hour after the completion of
the call and will remain available for one year. The telephone
replay will also be available approximately one hour after the
completion of the call and will remain available for 7 days. To
access the telephone replay from within the United States and
Canada, dial (866) 813-9403. From outside the United States, dial
+1 (929) 458-6194. The access code for the replay is 205780.
Please check the website investor.cencora.com for updates
regarding the timing of the live webcasts and for replay
information.
About Cencora
Cencora is a leading global pharmaceutical solutions
organization centered on improving the lives of people and animals
around the world. We partner with pharmaceutical innovators across
the value chain to facilitate and optimize market access to
therapies. Care providers depend on us for the secure, reliable
delivery of pharmaceuticals, healthcare products, and solutions.
Our 46,000+ worldwide team members contribute to positive health
outcomes through the power of our purpose: We are united in our
responsibility to create healthier futures. Cencora is ranked #11
on the Fortune 500 and #24 on the Global Fortune 500 with more than
$200 billion in annual revenue. Learn more at
investor.cencora.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230929976592/en/
Bennett S. Murphy Senior Vice President, Head of
Investor Relations and Treasury 610-727-3693
bmurphy@amerisourcebergen.com
Grafico Azioni Cencora (NYSE:COR)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Cencora (NYSE:COR)
Storico
Da Giu 2023 a Giu 2024